Applicant, as named in the Orange Book

Sentynl Theraps Inc

Next listed expiry: Nulibry on 9 Apr 2029. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Nulibry fosdenopterin hydrobromide	fosdenopterin hydrobromide	214018	9 Apr 2029	patent
Zokinvy · 2 strengths lonafarnib	lonafarnib	213969	26 Jul 2029	patent, carve-out possible
Zycubo copper histidinate	copper histidinate	211241	12 Jan 2033	exclusivity

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.